RMI is elated to share that Zara Anjum, our dedicated Clinical Research Associate of the Clinical Trials Unit (CTU), has achieved an outstanding feat by clinching the 1st position in the Certified Clinical Research Professional Training Course exam organized by Metrics Research.
We extend our heartfelt congratulations to her for this well-deserved accomplishment.
This achievement reflects Zara’s dedication to her field and the quality of training and support provided at RMI.
RMI is elated to share that Zara Anjum, our dedicated Clinical Research Associate of the Clinical Trials Unit (CTU), has achieved an outstanding feat by
AIMS Biosciences Project Manager Visits RMI CTU Chen Xhin Hui, Project Manager of Aims Biosciences, visited RMI’s Clinical Trials Unit (CTU) for monitoring, quality control,
A Multi-center, Randomized, Blinded, Placebo-controlled, Phase 3 Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021) as Booster in
A Phase 3, multicenter, randomized, double-blind, 48-week study of the clinical and antiviral effect of S 217622 compared with placebo in non-hospitalized high risk participants
Trial Name Disease Area CML Oncology Breast cancer Oncology CABG Cardiology Fungal infection evaluation Infectious Diseases Alzheimer’s Disease Neurology Alkylosing Spondyloarthritis Rheumatology Advanced Melanoma Oncology
